학술논문
Immunotherapy with HDC/IL-2 may be clinically efficacious in acute myeloid leukemia of normal karyotype
Document Type
Article
Author
Source
In: Human Vaccines and Immunotherapeutics . (Human Vaccines and Immunotherapeutics, 2 January 2020, 16(1):109-111)
Subject
Language
English
ISSN
2164554X
21645515
21645515